US › Healthcare

Aurora Cannabis Inc (ACB)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.85+0.52%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$67.6M

Revenue YoY

-23.4%

Net profit

$-4.0M

Profit YoY

-112.7%

EPS

$0.04

EPS estimate

$-0.13

Net margin

-6.0%

EPS came in at 0.04 against a street estimate of -0.13 — a beat of 130.8%.

Key statistics

Market cap

$241.8M

Forward P/E

109.9

P/B

0.63

Book value

$6.00

EPS (TTM)

$-0.66

52-week high

$6.67

52-week low

$2.56

50-day MA

$3.28

200-day MA

$3.62

Beta

1.45

Analyst view

Analysts rate Aurora Cannabis Inc a buy (4 buy, 2 hold, 0 sell out of 6) with an average price target of $6.23.

Shareholding

Insiders

1.21%

Institutions

9.35%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	1.97%
The Goldman Sachs Group Inc	1.67%
Renaissance Technologies Corp	1.20%
Morgan Stanley - Brokerage Accounts	0.41%
NATIONAL BANK OF CANADA /FI/	0.38%
AdvisorShares Investments, LLC	0.27%
UBS Group AG	0.24%
OZ Management LLC	0.16%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aurora Cannabis Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.